ID   UBE4B_HUMAN             Reviewed;        1302 AA.
AC   O95155; A8K8S9; G0ZJH6; O75169; O95338; Q5SZ12; Q5SZ16; Q96QD4;
AC   Q9BYI7;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   10-MAY-2017, entry version 152.
DE   RecName: Full=Ubiquitin conjugation factor E4 B {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000250|UniProtKB:Q9ES00};
DE   AltName: Full=Homozygously deleted in neuroblastoma 1 {ECO:0000312|EMBL:BAB40446.1};
DE   AltName: Full=RING-type E3 ubiquitin transferase E4 B;
DE   AltName: Full=Ubiquitin fusion degradation protein 2 {ECO:0000312|EMBL:AAD02233.1};
GN   Name=UBE4B {ECO:0000312|HGNC:HGNC:12500};
GN   Synonyms=HDNB1 {ECO:0000312|EMBL:BAB40446.1},
GN   KIAA0684 {ECO:0000312|EMBL:BAA31659.3},
GN   UFD2 {ECO:0000312|EMBL:AAD02233.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9653645; DOI=10.1006/geno.1997.5186;
RA   Onyango P., Lubyova B., Gardellin P., Kurzbauer R., Weith A.;
RT   "Molecular cloning and expression analysis of five novel genes in
RT   chromosome 1p36.";
RL   Genomics 50:187-198(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Substantia nigra;
RX   PubMed=10980605; DOI=10.1038/sj.onc.1203786;
RA   Ohira M., Kageyama H., Mihara M., Furuta S., Machida T.,
RA   Shishikura T., Takayasu H., Islam A., Nakamura Y., Takahashi M.,
RA   Tomioka N., Sakiyama S., Kaneko Y., Toyoda A., Hattori M., Sakaki Y.,
RA   Ohki M., Horii A., Soeda E., Inazawa J., Seki N., Kuma H., Nozawa I.,
RA   Nakagawara A.;
RT   "Identification and characterization of a 500-kb homozygously deleted
RT   region at 1p36.2-p36.3 in a neuroblastoma cell line.";
RL   Oncogene 19:4302-4307(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY,
RP   MUTAGENESIS OF ASP-109; ASP-121 AND ASP-123, AND CLEAVAGE BY CASPASES.
RX   PubMed=11802788; DOI=10.1042/0264-6021:3610587;
RA   Mahoney J.A., Odin J.A., White S.M., Shaffer D., Koff A.,
RA   Casciola-Rosen L., Rosen A.;
RT   "The human homologue of the yeast polyubiquitination factor Ufd2p is
RT   cleaved by caspase 6 and granzyme B during apoptosis.";
RL   Biochem. J. 361:587-595(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND ALTERNATIVE SPLICING.
RC   TISSUE=Skeletal muscle;
RX   PubMed=22174917; DOI=10.1371/journal.pone.0028861;
RA   Mammen A.L., Mahoney J.A., St Germain A., Badders N., Taylor J.P.,
RA   Rosen A., Spinette S.;
RT   "A novel conserved isoform of the ubiquitin ligase UFD2a/UBE4B is
RT   expressed exclusively in mature striated muscle cells.";
RL   PLoS ONE 6:E28861-E28861(2011).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [6]
RP   SEQUENCE REVISION.
RA   Ohara O., Suyama M., Nagase T., Ishikawa K.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1112-1302.
RA   Barrow I.K.-P., Boguski M.S., Touchman J.W., Spencer F.;
RT   "Full-insert sequence of mapped XREF EST.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-803, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-803, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31; SER-88; SER-90;
RP   SER-101 AND SER-803, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-84; SER-88; SER-90 AND
RP   SER-101, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-803 AND SER-1265, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103 AND SER-803, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-31; SER-101;
RP   SER-105; SER-124; SER-238; SER-383; SER-803 AND SER-1265, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Ubiquitin-protein ligase that probably functions as an
CC       E3 ligase in conjunction with specific E1 and E2 ligases. May also
CC       function as an E4 ligase mediating the assembly of polyubiquitin
CC       chains on substrates ubiquitinated by another E3 ubiquitin ligase.
CC       {ECO:0000250|UniProtKB:P54860, ECO:0000250|UniProtKB:Q9ES00}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000250|UniProtKB:Q9ES00}.
CC   -!- SUBUNIT: Interacts with VCP. {ECO:0000250|UniProtKB:Q9ES00}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9ES00}.
CC       Nucleus {ECO:0000250|UniProtKB:Q9ES00}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O95155-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95155-2; Sequence=VSP_007102;
CC       Name=3;
CC         IsoId=O95155-3; Sequence=VSP_007101, VSP_007102, VSP_007103;
CC         Note=No experimental confirmation available.;
CC       Name=4; Synonyms=UFD2a-7/7a, UFD2A-III;
CC         IsoId=O95155-4; Sequence=VSP_053372;
CC         Note=Expressed exclusively in mature striated muscle cells.;
CC   -!- TISSUE SPECIFICITY: Highest expression in ovary, testis, heart and
CC       skeletal muscle. Expression is low in colon, thymus and peripheral
CC       blood leukocytes. Almost undetectable in lung and spleen.
CC       {ECO:0000269|PubMed:11802788}.
CC   -!- DOMAIN: The U-box domain is required for the ubiquitin protein
CC       ligase activity. {ECO:0000250|UniProtKB:Q9ES00}.
CC   -!- PTM: Proteolytically cleaved by caspases during apoptosis. Cleaved
CC       efficiently at Asp-123 by caspase-6 and granzyme B. Cleaved with
CC       approximately 10-fold less efficiency at Asp-109 by caspase-3 and
CC       caspase-7. {ECO:0000269|PubMed:11802788}.
CC   -!- SIMILARITY: Belongs to the ubiquitin conjugation factor E4 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31659.3; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF043117; AAD02233.1; -; mRNA.
DR   EMBL; AB028839; BAB40446.1; -; mRNA.
DR   EMBL; AF331520; AAK69622.1; -; mRNA.
DR   EMBL; JF289274; AEK06331.1; -; mRNA.
DR   EMBL; AB014584; BAA31659.3; ALT_INIT; mRNA.
DR   EMBL; AK292444; BAF85133.1; -; mRNA.
DR   EMBL; AL590639; CAI14687.1; -; Genomic_DNA.
DR   EMBL; AL096841; CAI14687.1; JOINED; Genomic_DNA.
DR   EMBL; AL590639; CAI14688.1; -; Genomic_DNA.
DR   EMBL; AL096841; CAI14688.1; JOINED; Genomic_DNA.
DR   EMBL; AL096841; CAI21859.1; -; Genomic_DNA.
DR   EMBL; AL590639; CAI21859.1; JOINED; Genomic_DNA.
DR   EMBL; AL096841; CAI21860.1; -; Genomic_DNA.
DR   EMBL; AL590639; CAI21860.1; JOINED; Genomic_DNA.
DR   EMBL; BC093696; AAH93696.1; -; mRNA.
DR   EMBL; AF091093; AAC72962.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS110.1; -. [O95155-2]
DR   CCDS; CCDS41245.1; -. [O95155-1]
DR   PIR; T00358; T00358.
DR   RefSeq; NP_001099032.1; NM_001105562.2. [O95155-1]
DR   RefSeq; NP_006039.2; NM_006048.4. [O95155-2]
DR   RefSeq; XP_005263479.1; XM_005263422.1. [O95155-4]
DR   UniGene; Hs.593974; -.
DR   PDB; 2KRE; NMR; -; A=1208-1302.
DR   PDB; 3L1X; X-ray; 2.60 A; A=1208-1302.
DR   PDB; 3L1Z; X-ray; 3.17 A; B=1208-1302.
DR   PDBsum; 2KRE; -.
DR   PDBsum; 3L1X; -.
DR   PDBsum; 3L1Z; -.
DR   ProteinModelPortal; O95155; -.
DR   SMR; O95155; -.
DR   BioGrid; 115566; 77.
DR   DIP; DIP-40309N; -.
DR   IntAct; O95155; 8.
DR   MINT; MINT-2798575; -.
DR   STRING; 9606.ENSP00000343001; -.
DR   iPTMnet; O95155; -.
DR   PhosphoSitePlus; O95155; -.
DR   BioMuta; UBE4B; -.
DR   EPD; O95155; -.
DR   MaxQB; O95155; -.
DR   PaxDb; O95155; -.
DR   PeptideAtlas; O95155; -.
DR   PRIDE; O95155; -.
DR   Ensembl; ENST00000253251; ENSP00000253251; ENSG00000130939. [O95155-2]
DR   Ensembl; ENST00000343090; ENSP00000343001; ENSG00000130939. [O95155-1]
DR   GeneID; 10277; -.
DR   KEGG; hsa:10277; -.
DR   UCSC; uc001aqr.5; human. [O95155-1]
DR   CTD; 10277; -.
DR   DisGeNET; 10277; -.
DR   GeneCards; UBE4B; -.
DR   HGNC; HGNC:12500; UBE4B.
DR   HPA; HPA019219; -.
DR   MIM; 613565; gene.
DR   neXtProt; NX_O95155; -.
DR   OpenTargets; ENSG00000130939; -.
DR   PharmGKB; PA37148; -.
DR   eggNOG; KOG2042; Eukaryota.
DR   eggNOG; COG5113; LUCA.
DR   GeneTree; ENSGT00390000009300; -.
DR   HOGENOM; HOG000294109; -.
DR   HOVERGEN; HBG058129; -.
DR   InParanoid; O95155; -.
DR   KO; K10597; -.
DR   OMA; ECSFDSD; -.
DR   OrthoDB; EOG091G02B4; -.
DR   PhylomeDB; O95155; -.
DR   TreeFam; TF300802; -.
DR   BRENDA; 2.3.2.B12; 2681.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE4B; human.
DR   EvolutionaryTrace; O95155; -.
DR   GeneWiki; UBE4B; -.
DR   GenomeRNAi; 10277; -.
DR   PMAP-CutDB; O95155; -.
DR   PRO; PR:O95155; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000130939; -.
DR   CleanEx; HS_UBE4B; -.
DR   ExpressionAtlas; O95155; baseline and differential.
DR   Genevisible; O95155; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000151; C:ubiquitin ligase complex; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:Ensembl.
DR   GO; GO:0051117; F:ATPase binding; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; ISS:UniProtKB.
DR   GO; GO:0034450; F:ubiquitin-ubiquitin ligase activity; IBA:GO_Central.
DR   GO; GO:0008626; P:granzyme-mediated apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:MGI.
DR   GO; GO:0051865; P:protein autoubiquitination; IEA:Ensembl.
DR   GO; GO:0006513; P:protein monoubiquitination; IEA:Ensembl.
DR   GO; GO:0000209; P:protein polyubiquitination; IBA:GO_Central.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; TAS:UniProtKB.
DR   GO; GO:0009411; P:response to UV; IDA:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IBA:GO_Central.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR019474; Ub_conjug_fac_E4_core.
DR   InterPro; IPR003613; Ubox_domain.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF04564; U-box; 1.
DR   Pfam; PF10408; Ufd2P_core; 1.
DR   SMART; SM00504; Ubox; 1.
DR   PROSITE; PS51698; U_BOX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase; Ubl conjugation pathway.
FT   CHAIN         1   1302       Ubiquitin conjugation factor E4 B.
FT                                /FTId=PRO_0000194993.
FT   DOMAIN     1227   1300       U-box.
FT   SITE        109    110       Cleavage; by caspase-3 and caspase-7.
FT   SITE        123    124       Cleavage; by caspase-6 and granzyme B.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      23     23       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      31     31       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      84     84       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      88     88       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      90     90       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     101    101       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     103    103       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     105    105       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     124    124       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     383    383       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     803    803       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     969    969       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ES00}.
FT   MOD_RES    1265   1265       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    116       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_007101.
FT   VAR_SEQ     270    398       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:10980605,
FT                                ECO:0000303|PubMed:11802788,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9734811}.
FT                                /FTId=VSP_007102.
FT   VAR_SEQ     398    398       P -> PSMYDNPFSFLFLALSGDSSDEEDEEEDDDDGDGDD
FT                                EGGGGGDDFSCVQFGS (in isoform 4).
FT                                {ECO:0000303|PubMed:22174917}.
FT                                /FTId=VSP_053372.
FT   VAR_SEQ    1234   1234       D -> GKWTH (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_007103.
FT   VARIANT     605    605       V -> I (in dbSNP:rs17034499).
FT                                /FTId=VAR_052437.
FT   MUTAGEN     109    109       D->A: Abolishes cleavage by caspase-3 and
FT                                caspase-7. {ECO:0000269|PubMed:11802788}.
FT   MUTAGEN     121    121       D->A: Abolishes cleavage by caspase-6. No
FT                                effect on cleavage by granzyme B.
FT                                {ECO:0000269|PubMed:11802788}.
FT   MUTAGEN     123    123       D->A: Abolishes cleavage by caspase-6 and
FT                                granzyme B.
FT                                {ECO:0000269|PubMed:11802788}.
FT   HELIX      1230   1232       {ECO:0000244|PDB:3L1X}.
FT   TURN       1235   1237       {ECO:0000244|PDB:3L1X}.
FT   STRAND     1242   1246       {ECO:0000244|PDB:3L1X}.
FT   TURN       1248   1250       {ECO:0000244|PDB:2KRE}.
FT   STRAND     1252   1254       {ECO:0000244|PDB:3L1X}.
FT   HELIX      1255   1264       {ECO:0000244|PDB:3L1X}.
FT   TURN       1269   1271       {ECO:0000244|PDB:3L1X}.
FT   HELIX      1277   1279       {ECO:0000244|PDB:3L1X}.
FT   HELIX      1284   1298       {ECO:0000244|PDB:3L1X}.
SQ   SEQUENCE   1302 AA;  146185 MW;  6BAA80984B03E43B CRC64;
     MEELSADEIR RRRLARLAGG QTSQPTTPLT SPQRENPPGP PIAASAPGPS QSLGLNVHNM
     TPATSPIGAS GVAHRSQSSE GVSSLSSSPS NSLETQSQSL SRSQSMDIDG VSCEKSMSQV
     DVDSGIENME VDENDRREKR SLSDKEPSSG PEVSEEQALQ LVCKIFRVSW KDRDRDVIFL
     SSLSAQFKQN PKEVFSDFKD LIGQILMEVL MMSTQTRDEN PFASLTATSQ PIAAAARSPD
     RNLLLNTGSN PGTSPMFCSV ASFGASSLSS LYESSPAPTP SFWSSVPVMG PSLASPSRAA
     SQLAVPSTPL SPHSAASGTA AGSQPSSPRY RPYTVTHPWA SSGVSILSSS PSPPALASSP
     QAVPASSSRQ RPSSTGPPLP PASPSATSRR PSSLRISPSL GASGGASNWD SYSDHFTIET
     CKETDMLNYL IECFDRVGIE EKKAPKMCSQ PAVSQLLSNI RSQCISHTAL VLQGSLTQPR
     SLQQPSFLVP YMLCRNLPYG FIQELVRTTH QDEEVFKQIF IPILQGLALA AKECSLDSDY
     FKYPLMALGE LCETKFGKTH PVCNLVASLR LWLPKSLSPG CGRELQRLSY LGAFFSFSVF
     AEDDVKVVEK YFSGPAITLE NTRVVSQSLQ HYLELGRQEL FKILHSILLN GETREAALSY
     MAAVVNANMK KAQMQTDDRL VSTDGFMLNF LWVLQQLSTK IKLETVDPTY IFHPRCRITL
     PNDETRVNAT MEDVNDWLTE LYGDQPPFSE PKFPTECFFL TLHAHHLSIL PSCRRYIRRL
     RAIRELNRTV EDLKNNESQW KDSPLATRHR EMLKRCKTQL KKLVRCKACA DAGLLDESFL
     RRCLNFYGLL IQLLLRILDP AYPDITLPLN SDVPKVFAAL PEFYVEDVAE FLFFIVQYSP
     QALYEPCTQD IVMFLVVMLC NQNYIRNPYL VAKLVEVMFM TNPAVQPRTQ KFFEMIENHP
     LSTKLLVPSL MKFYTDVEHT GATSEFYDKF TIRYHISTIF KSLWQNIAHH GTFMEEFNSG
     KQFVRYINML INDTTFLLDE SLESLKRIHE VQEEMKNKEQ WDQLPRDQQQ ARQSQLAQDE
     RVSRSYLALA TETVDMFHIL TKQVQKPFLR PELGPRLAAM LNFNLQQLCG PKCRDLKVEN
     PEKYGFEPKK LLDQLTDIYL QLDCARFAKA IADDQRSYSK ELFEEVISKM RKAGIKSTIA
     IEKFKLLAEK VEEIVAKNAR AEIDYSDAPD EFRDPLMDTL MTDPVRLPSG TIMDRSIILR
     HLLNSPTDPF NRQTLTESML EPVPELKEQI QAWMREKQNS DH
//
